Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Endocrinol Metab (Seoul). 2021 Oct;36(5):1029-1041. doi: 10.3803/EnM.2021.1197. Epub 2021 Oct 21.
BACKGROUND: We estimated the effect of obesity on the incidence of cardiovascular disease (CVD) and mortality in women according to menopausal status. METHODS: Women aged 40 to 69 years under routine health check-ups provided by the National Health Insurance Service in 2009 were followed up till 2018 (n=2,208,559). RESULTS: In premenopausal women, a significant increment of mortality rate was found in underweight and obesity class II (hazard ratio [HR], 1.48; 95% confidence interval [CI], 1.31 to 1.67; and HR, 1.25; 95% CI, 1.12 to 1.39) compared to normal body mass index (BMI); overweight and obesity class I did not affect mortality rate. In postmenopausal women, obesity as well as overweight status reduced the risk of mortality compared to normal BMI (HR, 0.86; 95% CI, 0.83 to 0.88; and HR, 0.84; 95% CI, 0.82 to 0.86). By contrast, there was a linear association between CVD and BMI above the normal range irrespective of menopausal status, which was attenuated in diabetic women. CONCLUSION: The current study replicated the J-shaped relationship between BMI and mortality, being more prominent in the postmenopausal group. The risk of CVD was linearly increased as BMI was increased above the normal range irrespective of menopausal status.
背景:我们根据绝经状态估计了肥胖对女性心血管疾病(CVD)发病率和死亡率的影响。
方法:2009 年,在国家健康保险服务进行的常规健康检查中,对 40 至 69 岁的女性进行了随访,随访时间截止至 2018 年(n=2,208,559)。
结果:在绝经前女性中,与正常体重指数相比,体重过轻和肥胖 II 级(风险比[HR],1.48;95%置信区间[CI],1.31 至 1.67;和 HR,1.25;95%CI,1.12 至 1.39)的死亡率显著增加;超重和肥胖 I 级对死亡率没有影响。在绝经后女性中,与正常 BMI 相比,肥胖以及超重状态降低了死亡率风险(HR,0.86;95%CI,0.83 至 0.88;和 HR,0.84;95%CI,0.82 至 0.86)。相比之下,不论绝经状态如何,BMI 高于正常范围与 CVD 之间存在线性关联,而在糖尿病女性中,这种关联则减弱。
结论:本研究复制了 BMI 与死亡率之间的 J 形关系,在绝经后组中更为明显。不论绝经状态如何,BMI 高于正常范围时,CVD 的风险呈线性增加。
Endocrinol Metab (Seoul). 2021-10
Zhonghua Liu Xing Bing Xue Za Zhi. 2014-3
Front Endocrinol (Lausanne). 2024
Hum Reprod. 2017-12-1
Front Endocrinol (Lausanne). 2024
Front Cardiovasc Med. 2024-2-16
NPJ Parkinsons Dis. 2023-1-27
Korean Circ J. 2020-9
J Obes Metab Syndr. 2019-3
Am J Nephrol. 2016